Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Emerg Microbes Infect. 2020 Dec;9(1):787-793. doi: 10.1080/22221751.2020.1750307.
On 31 December 2019, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, China, and caused the outbreak of the Coronavirus Disease 2019 (COVID-19). To date, computed tomography (CT) findings have been recommended as major evidence for the clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the imaging characteristics and changes throughout the disease course in patients with COVID-19 in order to provide some help for clinicians. Typical CT findings included bilateral ground-glass opacity, pulmonary consolidation, and prominent distribution in the posterior and peripheral parts of the lungs. This review also provides a comparison between COVID-19 and other diseases that have similar CT findings. Since most patients with COVID-19 infection share typical imaging features, radiological examinations have an irreplaceable role in screening, diagnosis and monitoring treatment effects in clinical practice.
2019 年 12 月 31 日,一种严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)在中国湖北省武汉市出现,并引发了 2019 年冠状病毒病(COVID-19)疫情。迄今为止,计算机断层扫描(CT)结果已被推荐为中国湖北省 COVID-19 临床诊断的主要依据。本综述重点介绍了 COVID-19 患者疾病过程中的影像学特征和变化,以期为临床医生提供一些帮助。典型的 CT 表现包括双侧磨玻璃影、肺部实变,以及在后背部和外周部的显著分布。本综述还比较了 COVID-19 与其他具有相似 CT 表现的疾病。由于大多数 COVID-19 感染患者具有典型的影像学特征,因此放射学检查在临床实践中的筛查、诊断和监测治疗效果方面具有不可替代的作用。